+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Amines 1062444-54-5
1062444-54-5,MFCD32667006
Catalog No.:AA01UPZF

1062444-54-5 | 4-((6-AMINO-2-(2-METHOXYETHOXY)-8-OXO-7,8-DIHYDRO-9H-PURIN-9-YL)METHYL)BENZOIC ACID

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$145.00   $101.00
- +
10mg
≥98%
in stock  
$275.00   $192.00
- +
25mg
95%
in stock  
$458.00   $321.00
- +
100mg
95%
in stock  
$1,157.00   $810.00
- +
250mg
95%
in stock  
$1,633.00   $1,143.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA01UPZF
Chemical Name:
4-((6-AMINO-2-(2-METHOXYETHOXY)-8-OXO-7,8-DIHYDRO-9H-PURIN-9-YL)METHYL)BENZOIC ACID
CAS Number:
1062444-54-5
Molecular Formula:
C16H17N5O5
Molecular Weight:
359.3367
MDL Number:
MFCD32667006
SMILES:
COCCOc1nc(N)c2c(n1)n(Cc1ccc(cc1)C(=O)O)c(=O)[nH]2
Properties

Downstream Synthesis Route
6066-82-6    1062444-54-5   
2,5-dioxo-pyrrolidin-1-yl4-6-amino-8-hydroxy-2-(2-methoxyethoxy)purin-9-ylmethylbenzoate 

[1]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA-WO2007/24707,2007,A2Locationinpatent:Page/Pagecolumn19;27

[2]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA-WO2007/24707,2007,A2Locationinpatent:Page/Pagecolumn19;27

[3]CurrentPatentAssignee:SHENZHENUNIVERSITY-CN111053895,2020,ALocationinpatent:Paragraph0045-0051;0054-0057

[1]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA-WO2007/24707,2007,A2Locationinpatent:Page/Pagecolumn19;26

[1]CurrentPatentAssignee:UNIVERSITYOFCALIFORNIA-US2010/210598,2010,A1Locationinpatent:Page/Pagecolumntitlepage;13

4004-05-1    1062444-54-5   
(2R)‑3‑(((2‑(4‑((6‑amino‑2‑(2‑methoxyethoxy)‑8‑oxo‑7,8‑dihydro‑9H-purin‑9‑yl)methyl)benzamido)ethoxy)(hydroxy)phosphoryl)oxy)propane‑1,2‑diyldioleate 

[1]Gadd,AdamJ.R.;Castelletto,Valeria;Kabova,Elena;Shankland,Kenneth;Perrie,Yvonne;Hamley,Ian;Cobb,AlexanderJ.A.;Greco;Edwards,AlexanderD.[EuropeanJournalofPharmaceuticalSciences,2018,vol.123,p.268-276]

[2]CurrentPatentAssignee:UROGENPHARMALTD-US9173936,2015,B2Locationinpatent:Page/Pagecolumn43;44

C14H12ClN5O2 
  1062444-54-5 

[1]CurrentPatentAssignee:SHENZHENHORNETCORNBIOTECHNOLOGY-WO2017/197624,2017,A1

Literature

Title: Battistella C, et al. Delivery of Immunotherapeutic Nanoparticles to Tumors via Enzyme-Directed Assembly. Adv Healthc Mater. 2019 Dec;8(23):e1901105.

Title: Shinchi H, et al. Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides. Bioconjug Chem. 2015 Aug 19;26(8):1713-23.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1062444-54-5
Building Blocks
More >
Tags:1062444-54-5 Molecular Formula|1062444-54-5 MDL|1062444-54-5 SMILES|1062444-54-5 4-((6-AMINO-2-(2-METHOXYETHOXY)-8-OXO-7,8-DIHYDRO-9H-PURIN-9-YL)METHYL)BENZOIC ACID